Insider filing · ADPT
Robert Hershberg
Director
profile →
Adaptive Biotechnologies Corporation
ADPT · Healthcare · 80 filings in 24 months
ticker →
Robert Hershberg sold $402K of Adaptive Biotechnologies (ADPT)
Executed Mar 12 2025, disclosed Mar 12 2025, the same day.
Value, as filed
$402K
53,000 sh × $7.59
Executed
Mar 12 2025
the trade date, as filed
Disclosed
Mar 12 2025
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
RHRobert Hershberg (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $748K of ADPT (30,664 sh across 2 lots, as filed), executed Aug 18.
The name
ADPTHealthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Robert Hershberg in ADPT
ADPTSALE
Adaptive Biotechnologies Corporation
$748K30,664 sh across 2 lots
Exec Aug 18
Filed Aug 20 · 5:55 PM ET ADPTSALE Adaptive Biotechnologies Corporation $367K
22,968 sh × $16.00
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET